Trial Profile
Active specific immunotherapy with the 1E10 anti-idiotype vaccine in the treatment of patients with small-cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Racotumomab (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry record.
- 13 Sep 2011 New trial record